anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

11,719-11,736 of 319,975

filter-aware
17
The slide uses color coding to categorize priorities into Pandemic response, Workflow efficiency, and Care management capability.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
18
The table uses a 1-7 scale for survey responses; percentages represent respondents choosing 6 or 7.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
19
The slide uses a stacked bar chart approach to rank specialties by preference within each hospital category.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
20
The chart is a dot plot comparing three segments (Public L3, Public L2, Private) across 7 value drivers.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
21
Includes bilingual labels (English/Chinese).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit
22
The slide uses a central circular focal point 'Insights with Impact' to bridge the firm's expertise and analytical rigor with its sector and service focus.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
23
The slide uses a matrix-like structure to show vertical industry segments and horizontal functional/thematic practices.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
24
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
25
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting 1 hit
01
Slide 1
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
02
The slide provides a methodological overview of the survey sample, including familiarity, geography, sector, and functional role of respondents.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
The slide highlights the timing of an L.E.K. survey relative to the legislative process.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
05
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and InvestorsImpact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
06
The chart uses a grouped bar format to compare 'Before' and 'After' confidence scores (0-10 scale) with percentage change annotations.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
07
The chart uses a multi-select survey format, so percentages may not sum to 100%.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
08
The chart uses a custom layout with a central axis and directional arrows to indicate sentiment/impact.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
09
The chart displays multi-select survey data.Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit